Pharmabiz
 

EPD Solutions' Cardiac Mapping and Navigation System receives European regulatory approval

Tortola, British Virgin IslandsWednesday, February 28, 2018, 13:00 Hrs  [IST]

EPD Solutions (EPD), a member of the Hobart Group companies, announced that its Cardiac Mapping and Navigation System received CE mark approval. The system helps electrophysiologists navigate the heart by generating an accurate 3D map, while imaging and pinpointing the exact location and orientation of catheters in the heart during diagnostic and therapeutic procedures for cardiac arrhythmias.

“Receiving the CE mark is a very significant milestone for EPD,” said Professor Shlomo Ben-Haim, EPD’s founder and chairman.  Explaining that the system produces real-time highly detailed cardiac imaging and navigation when used with standard sensor-less EP catheters, Professor Ben-Haim added: “We are extremely eager to introduce physicians to our technology, which will reduce procedure costs, simplify navigation and treatment, and ultimately improve procedure efficacy.”

A unique feature offered by EPD’s system is the Panoramic View, which provides a flattened 3D view of the whole cardiac chamber.  “This feature simplifies navigation and treatment,” said Dr. Yitzhack Schwartz, chief medical director at EPD’s R&D subsidiary.  “Using the intuitive Panoramic View, the system operator can navigate and ablate as if holding a pen and writing on paper”.

EPD is planning commercial installations in several leading centers in Europe in the coming months.

Atrial fibrillation (AF) is an abnormal heart rhythm which is characterized by irregular and rapid beating.  As the most common arrhythmia, it affects about 3% of the population in North America and Europe and is the second leading cause of stroke.

EPD Solutions (EPD), a member of the Hobart Group companies, is dedicated to improving the efficacy and efficiency of minimally invasive catheter-based procedures performed to treat cardiac arrhythmias.

 
[Close]